Squarepoint’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $572K | Buy |
30,709
+19,724
| +180% | +$367K | ﹤0.01% | 1840 |
|
|
2025
Q1 | $199K | Sell |
10,985
-96
| -0.9% | -$1.74K | ﹤0.01% | 2369 |
|
|
2024
Q4 | $242K | Sell |
11,081
-4,082
| -27% | -$89K | ﹤0.01% | 2301 |
|
|
2024
Q3 | $415K | Buy |
+15,163
| New | +$415K | ﹤0.01% | 1856 |
|
|
2024
Q2 | – | Sell |
-13,642
| Closed | -$409K | – | 2597 |
|
|
2024
Q1 | $409K | Buy |
+13,642
| New | +$409K | ﹤0.01% | 1776 |
|
|
2022
Q1 | – | Sell |
-1,134
| Closed | -$80K | – | 2366 |
|
|
2021
Q4 | $80K | Buy |
+1,134
| New | +$80K | ﹤0.01% | 2351 |
|
|
2021
Q3 | – | Sell |
-2,098
| Closed | -$328K | – | 2342 |
|
|
2021
Q2 | $328K | Buy |
2,098
+943
| +82% | +$147K | ﹤0.01% | 1904 |
|
|
2021
Q1 | $219K | Buy |
1,155
+276
| +31% | +$52.3K | ﹤0.01% | 2115 |
|
|
2020
Q4 | $110K | Sell |
879
-3,313
| -79% | -$415K | ﹤0.01% | 2323 |
|
|
2020
Q3 | $456K | Buy |
4,192
+2,705
| +182% | +$294K | 0.01% | 1412 |
|
|
2020
Q2 | $179K | Buy |
1,487
+55
| +4% | +$6.62K | ﹤0.01% | 1782 |
|
|
2020
Q1 | $144K | Buy |
+1,432
| New | +$144K | ﹤0.01% | 1559 |
|